人体扩张性和缩性心肌病的单核分析
Mark Chaffin1, Irinna Papangeli2, Bridget Simonson1
1Precision Cardiology Laboratory and the Cardiovascular Disease Initiative, The Broad Institute, Cambridge, MA, USA.
Nature
|June 22, 2022
概括
研究人员使用单核RNA测序在心力衰竭中发现了独特的激活纤维细胞. 这一发现为心力衰竭提供了新的治疗点和生物标志物,改善了对心脏病的理解.
科学领域:
- 心血管生物学
- 分子心脏病学
- 基因组学
背景情况:
- 心脏衰竭是一个复杂的疾病,心脏功能受损.
- 之前的研究集中在主要的细胞类型上,
- 了解心力衰竭的全部分子情况对于开发有效治疗至关重要.
研究的目的:
- 在单细胞分辨率下全面地绘制心脏衰竭的分子变化.
- 识别参与心力衰竭病变的新细胞群和分子通路.
- 发现潜在的治疗点和心力衰竭的生物标志物.
主要方法:
- 从人类左心室样本中对近60万个核进行单核RNA测序.
- 对患有扩张性心肌病,高性心肌病和不失效的对照患者的样本进行分析.
- 在人类初级心脏纤维细胞中使用CRISPR敲击屏幕来研究纤维细胞状态的转变.
主要成果:
- 在单细胞分辨率下识别了心脏衰竭的广泛分子变化.
- 在心脏扩张和缩性肌肉病症中观察到融合的转录特征.
- 在心肌病性心脏中发现了一种独特的活化纤维细胞群,
- 通过CRISPR查发现了调节纤维细胞转变为肌纤维细胞的关键基因.
结论:
- 单核RNA测序为人类心脏在健康和疾病中的转录多样性提供了前所未有的洞察力.
- 激活的纤维细胞是心力衰竭的潜在治疗点.
- 这些发现为心力衰竭治疗提供了新的生物标志物和治疗策略.
相关概念视频
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
01:30Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21